Kaj Blennow Inst. of Neuroscience and Physiology, Dept. of Psychiatry and Neurochemistry Sahlgrenska Academy at University of Gothenburg Biography Publications Institution JoVE Articles Kaj Blennow has not added a biography. If you are Kaj Blennow and would like to personalize this page please email our Author Liaison for assistance. Publications Central and Peripheral Leptin and Agouti-Related Protein During and After Pregnancy in Relation to Weight Change Clinical Endocrinology. Nov, 2017 | Pubmed ID: 29154467 Obstructive Sleep Apnea Severity Affects Amyloid Burden in Cognitively Normal Elderly: A Longitudinal Study American Journal of Respiratory and Critical Care Medicine. Nov, 2017 | Pubmed ID: 29125327 Low-dose γ-secretase Inhibition Increases Secretion of Aβ Peptides and Intracellular Oligomeric Aβ Molecular and Cellular Neurosciences. Dec, 2017 | Pubmed ID: 29104140 24-month Intervention with a Specific Multinutrient in People with Prodromal Alzheimer's Disease (LipiDiDiet): a Randomised, Double-blind, Controlled Trial The Lancet. Neurology. Oct, 2017 | Pubmed ID: 29097166 Neurofilament Light Protein in CSF and Blood is Associated with Neurodegeneration and Disease Severity in Huntington's Disease R6/2 Mice Scientific Reports. Oct, 2017 | Pubmed ID: 29074982 A Parallel Reaction Monitoring Mass Spectrometric Method for Analysis of Potential CSF Biomarkers for Alzheimer's Disease Proteomics. Clinical Applications. Oct, 2017 | Pubmed ID: 29028155 Serum Tau and Neurological Outcome in Cardiac Arrest Annals of Neurology. Nov, 2017 | Pubmed ID: 28981963 Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders Proteomics. Clinical Applications. Oct, 2017 | Pubmed ID: 28972305 Intracranial Arterial 4D Flow in Individuals with Mild Cognitive Impairment is Associated with Cognitive Performance and Amyloid Positivity Journal of Alzheimer's Disease : JAD. 2017 | Pubmed ID: 28826187 A Review of Fluid Biomarkers for Alzheimer's Disease: Moving from CSF to Blood Neurology and Therapy. Jul, 2017 | Pubmed ID: 28733960 Strategic Roadmap for an Early Diagnosis of Alzheimer's Disease Based on Biomarkers The Lancet. Neurology. Aug, 2017 | Pubmed ID: 28721928 Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease Journal of Alzheimer's Disease : JAD. 2017 | Pubmed ID: 28697566 Cerebrospinal Fluid Monoamine Metabolite Profiles in Bipolar Disorder, ADHD, and Controls Journal of Neural Transmission (Vienna, Austria : 1996). Jun, 2017 | Pubmed ID: 28656371 Neuroinflammation and Tau Interact with Amyloid in Predicting Sleep Problems in Aging Independently of Atrophy Cerebral Cortex (New York, N.Y. : 1991). Jun, 2017 | Pubmed ID: 28655157 Increased Levels of Ascorbic Acid in the Cerebrospinal Fluid of Cognitively Intact Elderly Patients with Major Depression: a Preliminary Study Scientific Reports. Jun, 2017 | Pubmed ID: 28615661 A Season of American Football Is Not Associated with Changes in Plasma Tau Journal of Neurotrauma. Aug, 2017 | Pubmed ID: 28614998 Inflammation, Amyloid, and Atrophy in The Aging Brain: Relationships with Longitudinal Changes in Cognition Journal of Alzheimer's Disease : JAD. 2017 | Pubmed ID: 28505968 Serum Neurofilament Light As a Biomarker for Mild Traumatic Brain Injury in Contact Sports Neurology. May, 2017 | Pubmed ID: 28404801 Clinical Validity of Cerebrospinal Fluid Aβ42, Tau, and Phospho-tau As Biomarkers for Alzheimer's Disease in the Context of a Structured 5-phase Development Framework Neurobiology of Aging. Apr, 2017 | Pubmed ID: 28317649 Microstructural White Matter Alterations in Preclinical Alzheimer's Disease Detected Using Free Water Elimination Diffusion Tensor Imaging PloS One. 2017 | Pubmed ID: 28291839 Phenotypic Screening Identifies Modulators of Amyloid Precursor Protein Processing in Human Stem Cell Models of Alzheimer's Disease Stem Cell Reports. Mar, 2017 | Pubmed ID: 28285880 Astroglial Activation and Altered Amyloid Metabolism in Human Repetitive Concussion Neurology. Mar, 2017 | Pubmed ID: 28283595 Effects of Risperidone and Galantamine Treatment on Alzheimer's Disease Biomarker Levels in Cerebrospinal Fluid Journal of Alzheimer's Disease : JAD. Feb, 2017 | Pubmed ID: 28269767 Two-level Diagnostic Classification Using Cerebrospinal Fluid YKL-40 in Alzheimer's Disease Alzheimer's & Dementia : the Journal of the Alzheimer's Association. Mar, 2017 | Pubmed ID: 28263742 The Immune Response of the Human Brain to Abdominal Surgery Annals of Neurology. Mar, 2017 | Pubmed ID: 28253549 Genome-wide Association Study Identifies Four Novel Loci Associated with Alzheimer's Endophenotypes and Disease Modifiers Acta Neuropathologica. Feb, 2017 | Pubmed ID: 28247064 Tau or Neurofilament Light-Which is the More Suitable Biomarker for Huntington's Disease? PloS One. 2017 | Pubmed ID: 28241046 Author Response: Calcium Supplementation and Risk of Dementia in Women with Cerebrovascular Disease Neurology. Feb, 2017 | Pubmed ID: 28220015 Ex Vivo (18)O-labeling Mass Spectrometry Identifies a Peripheral Amyloid β Clearance Pathway Molecular Neurodegeneration. Feb, 2017 | Pubmed ID: 28219449 Predicting Progression to Dementia in Persons with Mild Cognitive Impairment Using Cerebrospinal Fluid Markers Alzheimer's & Dementia : the Journal of the Alzheimer's Association. Feb, 2017 | Pubmed ID: 28216393 The Effects of Different Familial Alzheimer's Disease Mutations on APP Processing in Vivo Alzheimer's Research & Therapy. Feb, 2017 | Pubmed ID: 28209190 Blood-based NfL: A Biomarker for Differential Diagnosis of Parkinsonian Disorder Neurology. Mar, 2017 | Pubmed ID: 28179466 Accuracy of Cerebrospinal Fluid Aβ1-42 Measurements: Evaluation of Pre-analytical Factors Using a Novel Elecsys Immunosassay Clinical Chemistry and Laboratory Medicine. Feb, 2017 | Pubmed ID: 28160541 Neurofilament Protein and Antineurofilament Antibodies Following Traumatic Brain Injury-Reply JAMA Neurology. Mar, 2017 | Pubmed ID: 28135356 Genome-wide Association Study Identifies MAPT Locus Influencing Human Plasma Tau Levels Neurology. Feb, 2017 | Pubmed ID: 28100725 Plasma Concentrations of Free Amyloid β Cannot Predict the Development of Alzheimer's Disease Alzheimer's & Dementia : the Journal of the Alzheimer's Association. Jan, 2017 | Pubmed ID: 28073031 Increased Blood-brain Barrier Permeability is Associated with Dementia and Diabetes but Not Amyloid Pathology or APOE Genotype Neurobiology of Aging. Mar, 2017 | Pubmed ID: 28061383 Effect of Spinal Manometers on Cerebrospinal Fluid Amyloid-β Concentration Journal of Alzheimer's Disease : JAD. 2017 | Pubmed ID: 28059797 Improved Cerebrospinal Fluid-Based Discrimination Between Alzheimer's Disease Patients and Controls After Correction for Ventricular Volumes Journal of Alzheimer's Disease : JAD. 2017 | Pubmed ID: 28059783 Expanding the Cerebrospinal Fluid Endopeptidome Proteomics. Mar, 2017 | Pubmed ID: 28044435 Delineating Amyloid Plaque Associated Neuronal Sphingolipids in Transgenic Alzheimer's Disease Mice (tgArcSwe) Using MALDI Imaging Mass Spectrometry ACS Chemical Neuroscience. Feb, 2017 | Pubmed ID: 27984697 The Effects of Gene Mutations On Default Mode Network In Familial Alzheimer's Disease Journal of Alzheimer's Disease : JAD. 2017 | Pubmed ID: 27911308 Feasibility of Lumbar Puncture in the Study of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Subjects with Down Syndrome Journal of Alzheimer's Disease : JAD. 2017 | Pubmed ID: 27858714 Association of Amyloid Pathology With Myelin Alteration in Preclinical Alzheimer Disease JAMA Neurology. Jan, 2017 | Pubmed ID: 27842175 CSF Neurofilament Light Levels Predict Hippocampal Atrophy in Cognitively Healthy Older Adults Neurobiology of Aging. Jan, 2017 | Pubmed ID: 27794264 Cerebrospinal Fluid Aβ42/40 Corresponds Better Than Aβ42 to Amyloid PET in Alzheimer's Disease Journal of Alzheimer's Disease : JAD. 2017 | Pubmed ID: 27792012 Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team Journal of Alzheimer's Disease : JAD. 2017 | Pubmed ID: 27662307 HNK-1 Carrier Glycoproteins Are Decreased in the Alzheimer's Disease Brain Molecular Neurobiology. Jan, 2017 | Pubmed ID: 26738850 Cerebrospinal Fluid Microglia and Neurodegenerative Markers in Twins Concordant and Discordant for Psychotic Disorders European Archives of Psychiatry and Clinical Neuroscience. Dec, 2016 | Pubmed ID: 28039552 Genome-wide, High-content SiRNA Screening Identifies the Alzheimer's Genetic Risk Factor FERMT2 As a Major Modulator of APP Metabolism Acta Neuropathologica. Dec, 2016 | Pubmed ID: 27933404 Neurofilaments in Blood and CSF for Diagnosis and Prediction of Onset in Creutzfeldt-Jakob Disease Scientific Reports. Dec, 2016 | Pubmed ID: 27929120 Traumatic Brain Injuries Nature Reviews. Disease Primers. 11, 2016 | Pubmed ID: 27853132 Serum Neurofilament Light Protein Predicts Clinical Outcome in Traumatic Brain Injury Scientific Reports. Nov, 2016 | Pubmed ID: 27819296 Cerebrospinal Fluid Biomarkers As a Measure of Disease Activity and Treatment Efficacy in Relapsing-remitting Multiple Sclerosis Journal of Neurochemistry. Oct, 2016 | Pubmed ID: 27787906 Plasma Tau in Alzheimer Disease Neurology. Sep, 2016 | Pubmed ID: 27694257 Preclinical Amyloid-β and Axonal Degeneration Pathology in Delirium Journal of Alzheimer's Disease : JAD. Sep, 2016 | Pubmed ID: 27662296 Neurochemical Aftermath of Repetitive Mild Traumatic Brain Injury JAMA Neurology. Sep, 2016 | Pubmed ID: 27654934 Cerebrospinal Fluid Amyloid Beta and Tau Concentrations Are Not Modulated by 16 Weeks of Moderate- to High-Intensity Physical Exercise in Patients with Alzheimer Disease Dementia and Geriatric Cognitive Disorders. Sep, 2016 | Pubmed ID: 27643858 No Diurnal Variation of Classical and Candidate Biomarkers of Alzheimer's Disease in CSF Molecular Neurodegeneration. 2016 | Pubmed ID: 27605218 CSF Profiling of the Human Brain Enriched Proteome Reveals Associations of Neuromodulin and Neurogranin to Alzheimer's Disease Proteomics. Clinical Applications. Sep, 2016 | Pubmed ID: 27604409 Associations Between Performance On an Abbreviated CogState Battery, Other Measures of Cognitive Function, And Biomarkers in People at Risk For Alzheimer's Disease Journal of Alzheimer's Disease : JAD. Sep, 2016 | Pubmed ID: 27589532 Specific Triazine Herbicides Induce Amyloid-β42 Production Journal of Alzheimer's Disease : JAD. Sep, 2016 | Pubmed ID: 27589520 Reference Measurement Procedure for CSF Amyloid Beta (Aβ)1-42 and the CSF Aβ1-42 /Aβ1-40 Ratio - a Cross-validation Study Against Amyloid PET Journal of Neurochemistry. Aug, 2016 | Pubmed ID: 27579672 Cerebrospinal Fluid Tau, Neurogranin, and Neurofilament Light in Alzheimer's Disease EMBO Molecular Medicine. Oct, 2016 | Pubmed ID: 27534871 Cerebrospinal Fluid Interferon Alpha Levels Correlate with Neurocognitive Impairment in Ambulatory HIV-Infected Individuals Journal of Neurovirology. Jul, 2016 | Pubmed ID: 27400930 Blood Biomarkers Indicate Mild Neuroaxonal Injury and Increased Amyloid β Production After Transient Hypoxia During Breath-hold Diving Brain Injury. 2016 | Pubmed ID: 27389622 Low Circulating Acute Brain-Derived Neurotrophic Factor Levels Are Associated With Poor Long-Term Functional Outcome After Ischemic Stroke Stroke; a Journal of Cerebral Circulation. Jul, 2016 | Pubmed ID: 27301948 CSF Aβ1-42 - an Excellent but Complicated Alzheimer's Biomarker - a Route to Standardisation Clinica Chimica Acta; International Journal of Clinical Chemistry. May, 2016 | Pubmed ID: 27216941 Cerebrospinal Fluid Biomarkers in Alzheimer's and Parkinson's Diseases-From Pathophysiology to Clinical Practice Movement Disorders : Official Journal of the Movement Disorder Society. Jun, 2016 | Pubmed ID: 27145480 Cerebrospinal Fluid Levels of Insulin, Leptin, and Agouti-related Protein in Relation to BMI in Pregnant Women Obesity (Silver Spring, Md.). Jun, 2016 | Pubmed ID: 27130070 A Single Dose of the γ-secretase Inhibitor Semagacestat Alters the Cerebrospinal Fluid Peptidome in Humans Alzheimer's Research & Therapy. 2016 | Pubmed ID: 26948580 Increased Amyloidogenic APP Processing in APOE ɛ4-negative Individuals with Cerebral β-amyloidosis Nature Communications. 2016 | Pubmed ID: 26948379 YKL-40 is a CSF Biomarker of Intrathecal Inflammation in Secondary Progressive Multiple Sclerosis Journal of Neuroimmunology. Mar, 2016 | Pubmed ID: 26943959 Cerebral White Matter Lesions - Associations with Aβ Isoforms and Amyloid PET Scientific Reports. 2016 | Pubmed ID: 26856756 Effect of Docosahexaenoic Acid on a Biomarker of Head Trauma in American Football Medicine and Science in Sports and Exercise. Jun, 2016 | Pubmed ID: 26765633 Increased Cerebrospinal Fluid Soluble TREM2 Concentration in Alzheimer's Disease Molecular Neurodegeneration. 2016 | Pubmed ID: 26754172 Serum Neurofilament Light in American Football Athletes over the Course of a Season Journal of Neurotrauma. Oct, 2016 | Pubmed ID: 26700106 Cerebrospinal Fluid Biomarker for Alzheimer Disease Predicts Postoperative Cognitive Dysfunction Anesthesiology. Feb, 2016 | Pubmed ID: 26580833 Technical Performance of a Novel, Fully Automated Electrochemiluminescence Immunoassay for the Quantitation Of β-amyloid (1-42) in Human Cerebrospinal Fluid Alzheimer's & Dementia : the Journal of the Alzheimer's Association. May, 2016 | Pubmed ID: 26555316 Neurogranin and YKL-40: Independent Markers of Synaptic Degeneration and Neuroinflammation in Alzheimer's Disease Alzheimer's Research & Therapy. 2015 | Pubmed ID: 26698298 APLP1 As a Cerebrospinal Fluid Biomarker for γ-secretase Modulator Treatment Alzheimer's Research & Therapy. 2015 | Pubmed ID: 26689589 Cerebrospinal Fluid Markers of Central Nervous System Injury in Decompression Illness - a Case-controlled Pilot Study Diving and Hyperbaric Medicine. Dec, 2015 | Pubmed ID: 26687311 The Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative Diseases Frontiers in Neurology. 2015 | Pubmed ID: 26528237 The Past and the Future of Alzheimer's Disease CSF Biomarkers-a Journey Toward Validated Biochemical Tests Covering the Whole Spectrum of Molecular Events Frontiers in Neuroscience. 2015 | Pubmed ID: 26483625 Cerebrospinal Fluid Substance P Concentrations Are Elevated in Patients with Alzheimer's Disease Neuroscience Letters. Nov, 2015 | Pubmed ID: 26453765 Greater Specificity for Cerebrospinal Fluid P-tau231 over P-tau181 in the Differentiation of Healthy Controls from Alzheimer's Disease Journal of Alzheimer's Disease : JAD. 2015 | Pubmed ID: 26444757 Dissecting IWG-2 Typical and Atypical Alzheimer's Disease: Insights from Cerebrospinal Fluid Analysis Journal of Neurology. Dec, 2015 | Pubmed ID: 26410752 Increased Cerebrospinal Fluid Level of Insulin-like Growth Factor-II in Male Patients with Alzheimer's Disease Journal of Alzheimer's Disease : JAD. 2015 | Pubmed ID: 26402100 Does Caffeine Consumption Modify Cerebrospinal Fluid Amyloid-β Levels in Patients with Alzheimer's Disease? Journal of Alzheimer's Disease : JAD. 2015 | Pubmed ID: 26401784 Case Report of Complex Amyotrophic Lateral Sclerosis with Cognitive Impairment and Cortical Amyloid Deposition Journal of Alzheimer's Disease : JAD. 2015 | Pubmed ID: 26401701 Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease JAMA Neurology. Oct, 2015 | Pubmed ID: 26258692 Alzheimer's Disease Cerebrospinal Fluid Biomarker in Cognitively Normal Subjects Brain : a Journal of Neurology. Sep, 2015 | Pubmed ID: 26220940 Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia: a Meta-analysis JAMA. May, 2015 | Pubmed ID: 25988462 Serum Visinin-like Protein-1 in Concussed Professional Ice Hockey Players Brain Injury. 2015 | Pubmed ID: 25955117 Amyloid Biomarkers in Alzheimer's Disease Trends in Pharmacological Sciences. May, 2015 | Pubmed ID: 25840462 CSF Biomarkers for the Differential Diagnosis of Alzheimer's Disease: A Large-scale International Multicenter Study Alzheimer's & Dementia : the Journal of the Alzheimer's Association. Nov, 2015 | Pubmed ID: 25804998 Cerebrospinal Fluid Levels of the Synaptic Protein Neurogranin Correlates with Cognitive Decline in Prodromal Alzheimer's Disease Alzheimer's & Dementia : the Journal of the Alzheimer's Association. Oct, 2015 | Pubmed ID: 25533203 Rarity of the Alzheimer Disease-protective APP A673T Variant in the United States JAMA Neurology. Feb, 2015 | Pubmed ID: 25531812 Cerebrospinal Fluid Biomarkers in Trials for Alzheimer and Parkinson Diseases Nature Reviews. Neurology. Jan, 2015 | Pubmed ID: 25511894 Genetic Variants of GSK3B Are Associated with Biomarkers for Alzheimer's Disease and Cognitive Function Journal of Alzheimer's Disease : JAD. 2015 | Pubmed ID: 25420549 Clinical Utility of Cerebrospinal Fluid Biomarkers in the Diagnosis of Early Alzheimer's Disease Alzheimer's & Dementia : the Journal of the Alzheimer's Association. Jan, 2015 | Pubmed ID: 24795085 Taking Stock: A Multistakeholder Perspective on Improving the Delivery of Care and the Development of Treatments for Alzheimer's Disease Alzheimer's & Dementia : the Journal of the Alzheimer's Association. Apr, 2015 | Pubmed ID: 24751826 Agitation in Dementia: Relation to Core Cerebrospinal Fluid Biomarker Levels Dementia and Geriatric Cognitive Disorders Extra. May, 2014 | Pubmed ID: 25298777 Tau, S-100 Calcium-binding Protein B, and Neuron-specific Enolase As Biomarkers of Concussion-reply JAMA Neurology. Jul, 2014 | Pubmed ID: 25023557 Levels of Cerebrospinal Fluid α-synuclein Oligomers Are Increased in Parkinson's Disease with Dementia and Dementia with Lewy Bodies Compared to Alzheimer's Disease Alzheimer's Research & Therapy. 2014 | Pubmed ID: 24987465 Higher CSF Interleukin-6 and CSF Interleukin-8 in Current Depression in Older Women. Results from a Population-based Sample Brain, Behavior, and Immunity. Oct, 2014 | Pubmed ID: 24858658 Advancing Research Diagnostic Criteria for Alzheimer's Disease: the IWG-2 Criteria The Lancet. Neurology. Jun, 2014 | Pubmed ID: 24849862 Mass Spectrometry-based Candidate Reference Measurement Procedure for Quantification of Amyloid-β in Cerebrospinal Fluid Clinical Chemistry. Jul, 2014 | Pubmed ID: 24842955 CSF Aβ42 Predicts Early-onset Dementia in Parkinson Disease Neurology. May, 2014 | Pubmed ID: 24748671 The Cerebrospinal Fluid "Alzheimer Profile": Easily Said, but What Does It Mean? Alzheimer's & Dementia : the Journal of the Alzheimer's Association. Nov, 2014 | Pubmed ID: 24721526 [Exercise and Weight Loss Does Not Reduce Cardiovascular Risk in Type 2 Diabetes] Lakartidningen. Jan 15-28, 2014 | Pubmed ID: 24552015 Automated Cerebrospinal Fluid Cell Count--new Reference Ranges and Evaluation of Its Clinical Use in Central Nervous System Infections Clinical Biochemistry. Jan, 2014 | Pubmed ID: 24275252 Cerebrospinal Fluid Biomarkers in Cardiac Arrest Survivors Resuscitation. Feb, 2014 | Pubmed ID: 24231570 Increased CSF Levels of Phosphorylated Neurofilament Heavy Protein Following Bout in Amateur Boxers PloS One. 2013 | Pubmed ID: 24260563 CSF Presenilin-1 Complexes Are Increased in Alzheimer's Disease Acta Neuropathologica Communications. Aug, 2013 | Pubmed ID: 24252417 Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid As a Biomarker for Alzheimer's Disease PloS One. 2013 | Pubmed ID: 23799095 The Application of Cerebrospinal Fluid Biomarkers in Early Diagnosis of Alzheimer Disease The Medical Clinics of North America. May, 2013 | Pubmed ID: 23642576 Acute and Chronic Traumatic Encephalopathies: Pathogenesis and Biomarkers Nature Reviews. Neurology. Apr, 2013 | Pubmed ID: 23558985 Soluble Amyloid Precursor Protein α and β in CSF in Alzheimer's Disease Brain Research. Jun, 2013 | Pubmed ID: 23541617 Dose and Plasma Concentration of Galantamine in Alzheimer's Disease - Clinical Application Alzheimer's Research & Therapy. 2013 | Pubmed ID: 23286718 Serum Levels of LIGHT in MS Multiple Sclerosis (Houndmills, Basingstoke, England). Jun, 2013 | Pubmed ID: 23037546 Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: More to Come? Journal of Alzheimer's Disease : JAD. 2013 | Pubmed ID: 22710917 The Neuropathology and Neurobiology of Traumatic Brain Injury Neuron. Dec, 2012 | Pubmed ID: 23217738 Fluid Biomarkers in Alzheimer Disease Cold Spring Harbor Perspectives in Medicine. Sep, 2012 | Pubmed ID: 22951438 Low Cerebrospinal Fluid Sulfatide Predicts Progression of White Matter Lesions: The LADIS Study Dementia and Geriatric Cognitive Disorders. 2012 | Pubmed ID: 22922641 Reference Measurement Procedures for Alzheimer's Disease Cerebrospinal Fluid Biomarkers: Definitions and Approaches with Focus on Amyloid β42 Biomarkers in Medicine. Aug, 2012 | Pubmed ID: 22917143 Proficiency Testing Programs for Alzheimer's Disease Cerebrospinal Fluid Biomarkers Biomarkers in Medicine. Aug, 2012 | Pubmed ID: 22917142 Peptidome Analysis of Cerebrospinal Fluid by LC-MALDI MS PloS One. 2012 | Pubmed ID: 22880031 CSF T-Tau/Aβ42 Predicts White Matter Microstructure in Healthy Adults at Risk for Alzheimer's Disease PloS One. 2012 | Pubmed ID: 22701578 An Online Nano-LC-ESI-FTICR-MS Method for Comprehensive Characterization of Endogenous Fragments from Amyloid β and Amyloid Precursor Protein in Human and Cat Cerebrospinal Fluid Journal of Mass Spectrometry : JMS. May, 2012 | Pubmed ID: 22576872 CSF-biomarkers in Olympic Boxing: Diagnosis and Effects of Repetitive Head Trauma PloS One. 2012 | Pubmed ID: 22496755 Biomarkers for Microglial Activation in Alzheimer's Disease International Journal of Alzheimer's Disease. 2011 | Pubmed ID: 22114747 Cerebrospinal Fluid Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Combination with Subcortical and Cortical Biomarkers in Vascular Dementia and Alzheimer's Disease Journal of Alzheimer's Disease : JAD. 2011 | Pubmed ID: 21860087 Identification of Novel α-synuclein Isoforms in Human Brain Tissue by Using an Online NanoLC-ESI-FTICR-MS Method Neurochemical Research. Nov, 2011 | Pubmed ID: 21674238 Biomarker-based Dissection of Neurodegenerative Diseases Progress in Neurobiology. Dec, 2011 | Pubmed ID: 21524681 Genetic Association of Sequence Variants Near AGER/NOTCH4 and Dementia Journal of Alzheimer's Disease : JAD. 2011 | Pubmed ID: 21297263 Impaired Lipoprotein Receptor-mediated Peripheral Binding of Plasma Amyloid-β is an Early Biomarker for Mild Cognitive Impairment Preceding Alzheimer's Disease Journal of Alzheimer's Disease : JAD. 2011 | Pubmed ID: 21157031 Cerebrospinal Fluid Analysis Should Be Considered in Patients with Cognitive Problems International Journal of Alzheimer's Disease. Jul, 2010 | Pubmed ID: 21487447 Use of Theragnostic Markers to Select Drugs for Phase II/III Trials for Alzheimer Disease Alzheimer's Research & Therapy. Nov, 2010 | Pubmed ID: 21122172 Biomarkers in Alzheimer's Disease Drug Development Nature Medicine. Nov, 2010 | Pubmed ID: 21052077 Neurogranin in Cerebrospinal Fluid As a Marker of Synaptic Degeneration in Alzheimer's Disease Brain Research. Nov, 2010 | Pubmed ID: 20875798 Pleiotropy in the Presence of Allelic Heterogeneity: Alternative Genetic Models for the Influence of APOE on Serum LDL, CSF Amyloid-β42, and Dementia Journal of Alzheimer's Disease : JAD. 2010 | Pubmed ID: 20847432 Confounding Factors Influencing Amyloid Beta Concentration in Cerebrospinal Fluid International Journal of Alzheimer's Disease. Jul, 2010 | Pubmed ID: 20798852 Lessons from Multicenter Studies on CSF Biomarkers for Alzheimer's Disease International Journal of Alzheimer's Disease. Jul, 2010 | Pubmed ID: 20721354 Diagnosis-independent Alzheimer Disease Biomarker Signature in Cognitively Normal Elderly People Archives of Neurology. Aug, 2010 | Pubmed ID: 20697045 Effects of Cerebrovascular Disease on Amyloid Precursor Protein Metabolites in Cerebrospinal Fluid Cerebrospinal Fluid Research. Jul, 2010 | Pubmed ID: 20673341 Acute Effect on the Aβ Isoform Pattern in CSF in Response to γ-secretase Modulator and Inhibitor Treatment in Dogs Journal of Alzheimer's Disease : JAD. 2010 | Pubmed ID: 20634579 Is It Time for Biomarker-based Diagnostic Criteria for Prodromal Alzheimer's Disease? Alzheimer's Research & Therapy. Apr, 2010 | Pubmed ID: 20441609 Biochemical Markers in Alzheimer's Disease Clinical Trials Biomarkers in Medicine. Feb, 2010 | Pubmed ID: 20387305 Association of Nrf2-encoding NFE2L2 Haplotypes with Parkinson's Disease BMC Medical Genetics. Mar, 2010 | Pubmed ID: 20196834 Analysis of Lipid Pathway Genes Indicates Association of Sequence Variation Near SREBF1/TOM1L2/ATPAF2 with Dementia Risk Human Molecular Genetics. May, 2010 | Pubmed ID: 20167577 Distinct Cerebrospinal Fluid Amyloid Beta Peptide Signatures in Sporadic and PSEN1 A431E-associated Familial Alzheimer's Disease Molecular Neurodegeneration. Jan, 2010 | Pubmed ID: 20145736 Is There a CSF Biomarker Profile Related to Depression in Elderly Women? Psychiatry Research. Apr, 2010 | Pubmed ID: 20132991 Nrf2-encoding NFE2L2 Haplotypes Influence Disease Progression but Not Risk in Alzheimer's Disease and Age-related Cataract Mechanisms of Ageing and Development. Feb, 2010 | Pubmed ID: 20064547 Converging Molecular Pathways in Human Neural Development and Degeneration Neuroscience Research. Mar, 2010 | Pubmed ID: 19961883 Kinesin Light Chain 1 Gene Haplotypes in Three Conformational Diseases Neuromolecular Medicine. Sep, 2010 | Pubmed ID: 19911314 Total and Phosphorylated Tau Protein As Biological Markers of Alzheimer's Disease Experimental Gerontology. Jan, 2010 | Pubmed ID: 19853650 Biological Markers of Amyloid Beta-related Mechanisms in Alzheimer's Disease Experimental Neurology. Jun, 2010 | Pubmed ID: 19815015 Amyloid Beta and APP As Biomarkers for Alzheimer's Disease Experimental Gerontology. Jan, 2010 | Pubmed ID: 19698775 Sequence Variation in SORL1 and Dementia Risk in Swedes Neurogenetics. Feb, 2010 | Pubmed ID: 19653016 CSF Biomarkers: Pinpointing Alzheimer Pathogenesis Annals of the New York Academy of Sciences. Oct, 2009 | Pubmed ID: 19906258 Subcortical Vascular Dementia Biomarker Pattern in Mild Cognitive Impairment Dementia and Geriatric Cognitive Disorders. 2009 | Pubmed ID: 19864909 Sustained Release of Neuron-specific Enolase to Serum in Amateur Boxers Brain Injury. Aug, 2009 | Pubmed ID: 19636997 CSF Biomarkers and Incipient Alzheimer Disease in Patients with Mild Cognitive Impairment JAMA. Jul, 2009 | Pubmed ID: 19622817 A Survey of ABCA1 Sequence Variation Confirms Association with Dementia Human Mutation. Sep, 2009 | Pubmed ID: 19606474 Synaptic Retrogenesis and Amyloid-beta in Alzheimer's Disease Journal of Alzheimer's Disease : JAD. 2009 | Pubmed ID: 19158416 Cerebrospinal Fluid Alpha-synuclein in Neurodegenerative Disorders-a Marker of Synapse Loss? Neuroscience Letters. Feb, 2009 | Pubmed ID: 19022350 Evidence That the Gene Encoding Insulin Degrading Enzyme Influences Human Lifespan Human Molecular Genetics. Aug, 2008 | Pubmed ID: 18448515 Sample Preparation for Endopeptidomic Analysis in Human Cerebrospinal Fluid Karl T. Hansson1, Tobias Skillbäck1,2, Elin Pernevik1, Jessica Holmén-Larsson1, Gunnar Brinkmalm1, Kaj Blennow1,2, Henrik Zetterberg1,2,3, Johan Gobom1,2 1Inst. of Neuroscience and Physiology, Dept. of Psychiatry and Neurochemistry, Sahlgrenska Academy at University of Gothenburg, 2Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, 3Department of Molecular Neuroscience, UCL Institute of Neurology JoVE 56244 신경과학 Absolute Quantification of Aβ1-42 in CSF Using a Mass Spectrometric Reference Measurement Procedure Josef Pannee1,2, Kaj Blennow1,2, Henrik Zetterberg1,2,3, Erik Portelius1,2 1Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, 2Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, 3UCL Institute of Neurology, Queen Square JoVE 55386 의학
Sample Preparation for Endopeptidomic Analysis in Human Cerebrospinal Fluid Karl T. Hansson1, Tobias Skillbäck1,2, Elin Pernevik1, Jessica Holmén-Larsson1, Gunnar Brinkmalm1, Kaj Blennow1,2, Henrik Zetterberg1,2,3, Johan Gobom1,2 1Inst. of Neuroscience and Physiology, Dept. of Psychiatry and Neurochemistry, Sahlgrenska Academy at University of Gothenburg, 2Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, 3Department of Molecular Neuroscience, UCL Institute of Neurology JoVE 56244 신경과학
Absolute Quantification of Aβ1-42 in CSF Using a Mass Spectrometric Reference Measurement Procedure Josef Pannee1,2, Kaj Blennow1,2, Henrik Zetterberg1,2,3, Erik Portelius1,2 1Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, 2Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, 3UCL Institute of Neurology, Queen Square JoVE 55386 의학